Tom Gallen

Tom Gallen

Managing Editor, Europe

Birmingham, UK

Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.

Latest from Tom Gallen

Valbiotis Enters Women’s Health Arena With Menopause Supplement

French firm's new supplement combines seven ingredients to offer relief from common menopause symptoms.

Clarity For Certain Botanicals With EU Novel Food Updates

The latest round of updates to the European Commission's Novel Food Catalogue determine whether authorization is required for supplements containing certain botanical extracts.

Kiwifruit Supplement Falls Short In UK Health Claim Bid

UK rejects proposed health claim from AFT Pharma, “Green kiwifruit powder contributes to the maintenance of normal defecation.”

People On The Move: Appointments At Angelini, Pierre Fabre, Boots

A round-up of the latest European people moves: Angelini hires external affairs chief; Pierre Fabre appoints impact and reputation officer; Boots changes leadership at the top.

Nestlé Taps Into AI To Offer Personalized Supplement Advice

The Solgar Smart Mirror harnesses AI to deliver personalized wellness insights, according to Nestlé Health Science.

Valbiotis Ready To Deliver On Big Ambitions

The France-based dietary supplements firm is targeting sales in excess of €25m next year.